Harvest & Collection
PRODUCTS
-
Germfree’s Compounding Aseptic Containment Isolators use HEPA filters to provide the highest level of operator and product protection.
-
This collaborative automated sample handler eliminates manual sample handling enabling testing of large sample sets and collection of statistically significant data, while freeing analyst’s time. The FMS Automation Module has a sample capacity of hundreds of vials and can complete headspace testing with a throughput as high as 300 samples per hour.
-
Mycenax’s state-of-the-art biomanufacturing site is PIC/S GMP certified. Our highly qualified and well-trained team routinely manufactures high-quality biopharmaceutical products by mammalian cell culture and microbial fermentation processes. We continuously invest in our technologies and infrastructure to ensure that we constantly meet your evolving needs of today and tomorrow.
-
Access, interact with, and even adjudicate clinical trial imaging from the same platform where you manage all other study data.
-
Autodesk AutoCAD equips architects, engineers, and construction professionals with precision tools that will provide them with a variety of new capabilities.
WHITE PAPERS AND CASE STUDIES
-
Generate High Quality Data And Execute Full Factorial Design Of Experiments
Learn how a bioprocessing company supplemented their in-house bioreactor capacity and performed large-scale DOE studies using a cloud bioreactor facility.
-
Zero To Final Fill: How HUGEL Implemented Its First Single-Use Lines
As regulations tighten, biomanufacturers are adopting single-use tech to boost compliance, reduce labor, and streamline fill-finish operations from the ground up.
-
How Green Chemistry Initiatives Reduced Cost While Increasing Yield
Green process redesign improved yield, reduced waste and solvent use, and cut manufacturing costs by 30% while enabling efficient, scalable production of an oncology compound.
-
Recruiting High-Performing Sites To Beat Forecasted Trial Start Date
Explore a partnership that enabled Syneos Health to achieve its enrollment goals, increasing the likelihood of the study's success, and resulting in cost savings and maximized efficiency with minimal delays.
-
Understanding Real-World Patient Characterization And Safety Outcomes Of DEXTENZA
In this study, we can derive confirmation of DEXTENZA’s favorable safety profile across a broader surgical spectrum.
-
Expanding CDMO Advanced Therapy Manufacturing Capability With BSL-2LS cGMP Facility
See how one manufacturer expanded its production capacity with a modular BSL-2LS cGMP facility built to meet evolving CDMO needs while ensuring robust engineering controls and flexible design.
-
Authentic Engagement: Reaching Underserved Lupus Patients
By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.
-
Enhancing Novel Developability Through Automated MS Analytics
Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.
-
Sweet Success: How Hydrogen Peroxide Transformed Odor Control In Massive Sugar Facility Ponds
A sugar processing facility was experiencing hydrogen sulfide (H2S) odor issues in their process water stabilization ponds due to anaerobic conditions.
-
GeoTree - Delaware DOT Large Diameter Metal Plate Arch Rehabilitation With GeoSpray Geopolymer Mortar
Trenchless geopolymer technology provides a high-strength, structural solution for failing large-diameter arch culverts.This approach eliminates the need for costly bridge replacements, offering a 70-plus-year service life with minimal environmental impact and significantly faster project timelines.
-
Regulatory Affairs Project Manager
Discover how a ProPharma consultant effectively integrated tools, streamlined processes, and enhanced communications within a biotech company to ensure regulatory filings would be delivered promptly and with the highest level of quality.
-
Defining And Implementing Global Data Standards And Governance
Learn how ProPharma's expertise in data standards and governance is transforming research and development for a global biopharma leader.
NEWS
-
PNE Group Receives Permits For Three New Wind Farms In Germany7/8/2025
In the second quarter of 2025, the PNE Group received the necessary permits for the construction and operation of three onshore wind farms in the German states of Brandenburg, Hesse, and North Rhine-Westphalia.
-
KBR Expands Support For Saudi's Energy Future1/22/2025
KBR announced today it has been awarded a contract to support sustainable production of energy resources in Saudi Arabia by contributing to the delivery of Saudi Aramco’s Master Expansion Program and increasing gas handling capacity at key regional locations.
-
Baden-Württemberg's Largest Solar Park Now In Operation5/28/2025
EnBW has commissioned its solar park in Langenenslingen-Wilflingen (district of Biberach in the southwest of Germany).
-
Brown Astronomers Create New Technique To Eliminate Signals Disrupting Sensitive Radio Telescopes2/12/2025
Astronomers sifting through data from the Murchison Widefield Array, a radio telescope in Western Australia, found themselves confronting an unexpected mystery.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.